Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01476722 · ClinicalTrials.gov registry record · NA

Lens Wearing Experience and Biocompatibility of a Multi-Purpose Disinfecting Solution (MPDS)

A NA study of Healthy, sponsored by Alcon Research.

Completed
Registry status
NA
Development phase
125
Enrollment target
1
Study location

NCT01476722: Completed NA study of Healthy, sponsored by Alcon Research.

NCT01476722 is a NA study of Healthy that has completed, run by Alcon Research. The registered enrollment target is 125 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01476722, a NA study of Healthy, has completed, sponsored by Alcon Research.

COMPLETED
Registry status
NA
Development phase
125 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study was to evaluate the efficacy of a new multipurpose disinfecting solution in silicone hydrogel and soft contact lens wearers.

Primary Outcome

Corneal staining type was assessed by the investigator for each of 5 regions of the cornea, i.e., four quadrants plus central. The investigator instilled fluorescein dye and examined the cornea with a slit lamp, i.e., biomicroscope and a yellow filter. Corneal staining type was recorded on a 5-point scale for each region: 0-none; 1-micropunctate; 2-macropunctate; 3-coalesced macropunctate; 4-patch (\>/= 1mm). The five regions were summed, for a maximum score of 20. A lower score represents a mor

Conditions Studied

Interventions

  • DEVICE OPTI-FREE PureMoist multipurpose disinfecting solution

Study Locations (1)

Texas

  • Contact Alcon Call Center for Trial Locations - Fort Worth

Trial Details

FieldValue
Enrollment Target 125 participants
Start Date 2011-06
Est. Completion 2011-10
Phase NA
Alcon Research

275 total trials

What the finished NCT01476722 record still lists

NCT01476722 is an interventional study that assigns participants to a tested intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (81% lower).

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which OPTI-FREE PureMoist multipurpose disinfecting solution is the first listed.

NCT01476722 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT01476722 about?

NCT01476722 is a clinical study titled "Lens Wearing Experience and Biocompatibility of a Multi-Purpose Disinfecting Solution (MPDS)". The purpose of this study was to evaluate the efficacy of a new multipurpose disinfecting solution in silicone hydrogel and soft contact lens wearers.

What is the current status of trial NCT01476722?

This trial is currently completed. It is a NA study. The enrollment target is 125 participants. The study started on 2011-06. Estimated completion is 2011-10.

What conditions does trial NCT01476722 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT01476722?

The interventions under investigation include: OPTI-FREE PureMoist multipurpose disinfecting solution (DEVICE).

Who is sponsoring clinical trial NCT01476722?

This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01476722 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01476722's enrollment target sits among peer trials

125 176th of 1090 higher than 914 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02717039 · 125 participants

    Pharmacogenomics of Heparin-Induced Thrombocytopenia

  • NCT02763033 · 125 participants · Phase 2

    Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients

  • NCT02793999 · 125 participants

    Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia

  • NCT03003299 · 125 participants · NA

    PARTNER 3 Trial - Aortic Valve-in-Valve

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01476722, the US trial registry maintained by the National Library of Medicine. NCT01476722 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.